Selective Vagus Nerve Stimulation as a Therapeutic Approach for the Treatment of ARDS: A Rationale for Neuro-Immunomodulation in COVID-19 Disease
Open Access
- 13 April 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 15, 667036
Abstract
Acute respiratory distress syndrome (ARDS) is the most severe form of acute lung injury. It is induced by sepsis, aspiration, and pneumonia, including that caused by SARS coronavirus and human influenza viruses. The main pathophysiological mechanism of ARDS is a systemic inflammatory response. Vagus nerve stimulation (VNS) can limit cytokine production in the spleen and thereby dampen any systemic inflammation and inflammation-induced tissue damage in the lungs and other organs. However, the effects of increased parasympathetic outflow to the lungs when non-selective VNS is applied may result in bronchoconstriction, increased mucus secretion and enhance local pulmonary inflammatory activity; this may outweigh the beneficial systemic anti-inflammatory action of VNS. Organ/function-specific therapy can be achieved by imaging of localized fascicle activity within the vagus nerve and selective stimulation of identified organ-specific fascicles. This may be able to provide selective neuromodulation of different pathways within the vagus nerve and offer a novel means to improve outcome in ARDS. This has motivated this review in which we discuss the mechanisms of anti-inflammatory effects of VNS, progress in selective VNS techniques, and a possible application for ARDS.Keywords
Funding Information
- UK Research and Innovation
- National Institutes of Health
This publication has 57 references indexed in Scilit:
- A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleenGut, 2013
- Effects of Vagus Nerve Stimulation and Vagotomy on Systemic and Pulmonary Inflammation in a Two-Hit Model in RatsPLOS ONE, 2012
- Activation of Nicotinic Cholinergic Receptors Prevents Ventilator-Induced Lung Injury in RatsPLOS ONE, 2011
- α7-Cholinergic Receptor Mediates Vagal Induction of Splenic NorepinephrineThe Journal of Immunology, 2011
- Requisite Role of the Cholinergic α7 Nicotinic Acetylcholine Receptor Pathway in Suppressing Gram-Negative Sepsis-Induced Acute Lung Inflammatory InjuryThe Journal of Immunology, 2009
- Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory SitesScience, 2009
- Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemiaProceedings of the National Academy of Sciences of the United States of America, 2008
- A comparative study of three techniques for diameter selective fiber activation in the vagal nerve: anodal block, depolarizing prepulses and slowly rising pulsesJournal of Neural Engineering, 2008
- Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in ratsJournal of Thrombosis and Haemostasis, 2006
- Laryngopharyngeal Dysfunction From the Implant Vagal Nerve StimulatorThe Laryngoscope, 2003